Zobrazeno 1 - 10
of 816
pro vyhledávání: '"Rengstl B"'
Autor:
Mackensen A; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Haanen JBAG; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.; Leiden University Medical Center, Department of Oncology, Leiden, the Netherlands., Koenecke C; Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Alsdorf W; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wagner-Drouet E; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Borchmann P; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Heudobler D; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Ferstl B; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Klobuch S; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Bokemeyer C; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Desuki A; University Medical Center Mainz, 3rd Medical Department, Hematology and Oncology, Mainz, Germany., Lüke F; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; University Hospital Regensburg, Department of Internal Medicine III, Hematology and Oncology, Regensburg, Germany., Kutsch N; University Hospital of Cologne, Department I of Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Müller F; University Hospital Erlangen, Department of Internal Medicine 5, Hematology/Oncology, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Smit E; Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands., Hillemanns P; Hannover Medical School, Department of Gynecology and Obstetrics, Hannover, Germany., Karagiannis P; University Medical Center Hamburg-Eppendorf, Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Hamburg, Germany., Wiegert E; Bexon Clinical Consulting, Upper Montclair, NJ, USA., He Y; BioNTech SE, Mainz, Germany., Ho T; BioNTech US, Cambridge, MA, USA., Kang-Fortner Q; BioNTech US, Cambridge, MA, USA., Schlitter AM; BioNTech SE, Mainz, Germany., Schulz-Eying C; BioNTech SE, Mainz, Germany., Finlayson A; BioNTech SE, Mainz, Germany., Flemmig C; BioNTech SE, Mainz, Germany., Kühlcke K; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany., Preußner L; BioNTech SE, Mainz, Germany., Rengstl B; BioNTech SE, Mainz, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Türeci Ö; BioNTech SE, Mainz, Germany.; BioNTech US, Cambridge, MA, USA.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Şahin U; BioNTech SE, Mainz, Germany. Ugur.Sahin@biontech.de.; BioNTech US, Cambridge, MA, USA. Ugur.Sahin@biontech.de.; BioNTech Innovative Manufacturing Services GmbH, Idar-Oberstein, Germany. Ugur.Sahin@biontech.de.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany. Ugur.Sahin@biontech.de.
Publikováno v:
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2844-2853. Date of Electronic Publication: 2023 Oct 23.
Autor:
Mackensen, A., Haanen, J.B.A.G., Alsdorf, W., Koenecke, C., Wagner-Drouet, E., Borchmann, P., Heudobler, D., Busse, A., Klobuch, S., Kutsch, N., Müller, F., Bokemeyer, C., Desuki, A., Lueke, F., Ho, T., Vemuri, K., Preussner, L., Rengstl, B., Türeci, Ö., Sahin, U.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1274-S1275
Autor:
Birtel M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Voss RH; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Department of Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany., Reinhard K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Rengstl B; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Ouchan Y; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Michel K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Hayduk N; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Tillmann B; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Becker R; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Suchan M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Theobald M; Department of Hematology, Oncology, and Pneumology, University Cancer Center (UCT), University Medical Center (UMC) of Johannes Gutenberg University, Mainz, Germany., Oehm P; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Sahin U; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany.; Department of Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Aug 18; Vol. 2 (8), pp. 827-841. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).
Autor:
Mackensen, A., Haanen, J.B.A.G., Koenecke, C., Alsdorf, W., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Bokemeyer, C., Klobuch, S., Smit, E., Müller, F., Desuki, A., Lüke, F., Wiegert, E., Flemmig, C., Schulz-Eying, C., Rengstl, B., Preussner, L., Türeci, Ö., Sahin, U.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S1404-S1405
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krämer, Moritz1 (AUTHOR), Blanco, Nicolás E.2 (AUTHOR), Penzler, Jan-Ferdinand3 (AUTHOR), Davis, Geoffry A.1 (AUTHOR), Brandt, Benjamin1 (AUTHOR), Leister, Dario3 (AUTHOR), Kunz, Hans-Henning1 (AUTHOR) kunz@lmu.de
Publikováno v:
Scientific Reports. 11/26/2024, Vol. 14 Issue 1, p1-13. 13p.
Autor:
Kaur, Prabhjot1 (AUTHOR), Singh, Santosh Kumar1 (AUTHOR), Mishra, Manoj K.2 (AUTHOR), Singh, Shailesh1,3 (AUTHOR), Singh, Rajesh1,3 (AUTHOR) rsingh@msm.edu
Publikováno v:
Journal of Ovarian Research. 10/14/2024, Vol. 17 Issue 1, p1-21. 21p.
Autor:
Paternò Raddusa, Michele Salvatore1 (AUTHOR) michelepat93@gmail.com, Marino, Andrea2 (AUTHOR) andrea.marino@unict.it, Celesia, Benedetto Maurizio2 (AUTHOR) cacopard@unict.it, Spampinato, Serena1 (AUTHOR) serenaspampinato93@gmail.com, Giarratana, Carmen1 (AUTHOR) carmengiarratana15@gmail.com, Venanzi Rullo, Emmanuele1 (AUTHOR) emmanuele.venanzirullo@unime.it, Cacopardo, Bruno2 (AUTHOR) giuseppe.nunnari1@unict.it, Nunnari, Giuseppe2 (AUTHOR)
Publikováno v:
Infectious Disease Reports. Oct2024, Vol. 16 Issue 5, p846-863. 18p.
Autor:
Reinhard K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Rengstl B; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Oehm P; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Michel K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Billmeier A; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Hayduk N; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Klein O; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Kuna K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Ouchan Y; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Wöll S; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Christ E; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Weber D; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Suchan M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Bukur T; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Birtel M; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Jahndel V; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Mroz K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Hobohm K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Kranz L; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Diken M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Kühlcke K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Sahin U; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany. ugur.sahin@biontech.de.; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany.; Helmholtz Institute for Translational Oncology Mainz, HI-TRON Mainz, Obere Zahlbacher Str. 63, 55131 Mainz, Germany.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 Jan 24; Vol. 367 (6476), pp. 446-453. Date of Electronic Publication: 2020 Jan 02.